Onward Medical Company Description

Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord.

The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs.

Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.

Onward Medical N.V.

Country	Netherlands
Founded	2014
Industry	Biotechnology
Sector	Healthcare
Employees	99
CEO	David Marver

Contact Details

Address: Schimmelt 2 Eindhoven, NL-5656 Netherlands
Website	onwd.com

Stock Details

Ticker Symbol	ONWD
Exchange	Euronext Brussels
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	NL0015000HT4
SIC Code	3841

Key Executives

Name	Position
David L. Marver	Chief Executive Officer and Executive Director
Dr. Gregoire Courtine Ph.D.	Chief Scientific Officer and Director
Khaled Bahi	Interim Chief Financial Officer
Robert W. Odell	Vice President of Operations
Lorenzo Fanti	Vice President of Legal
Sarah Moore	Vice President of Global Marketing
Alexandre Casteau	Head of Strategy and Corporate Development
Julie Crom	Director of People and Culture